论文部分内容阅读
对１５年来开展肝癌二级预防的情况进行总结，表明选择肝癌高发区中的二、三类高危人群作为二级预防的主要对象并设立现场点，早期癌的检出率达８３０／１０万。对二级预防中发现的２２２例小肝癌的治疗及预后作了分析。结果：获手术切除的１５４例小肝癌１、２、３、５、１０年生存率分别为：９３％、７５．９％、６６．６％、５６．２％、４３．６％。行ＴＡＣＥ治疗的３６例小肝癌１、２年生存率分别为７０％、５４％。说明二级预防确能降低肝癌死亡率，提高生存率。
The summary of the secondary prevention of liver cancer over the past 15 years shows that the second and third class high-risk population in the high incidence area of liver cancer is selected as the main target of secondary prevention and the site is set up. The detection rate of early cancer is 830 per 100,000. The treatment and prognosis of 222 cases of small hepatocellular carcinoma found in secondary prevention were analyzed. Results: The 1, 2, 3, 5, and 10 year survival rates of 154 cases of small hepatocellular carcinoma were 93%, 75.9%, 66.6%, 56.2%, and 43.6%, respectively. The 1-year and 2-year survival rates of 36 cases of small hepatocellular carcinoma treated with TACE were 70% and 54%, respectively. This shows that secondary prevention can actually reduce liver cancer mortality and improve survival.